Monocrotaline Pyrrole-Induced Pulmonary Hypertension in Fawn-Hooded Rats with Platelet Storage Pool Deficiency: 5-Hydroxytryptamine Uptake by Isolated, Perfused Lungs

Summary

Platelets are believed to be involved in the development of monocrotaline pyrrole (MCTP)-induced pulmonary hypertension. To help identify the role of the platelet, the cardiopulmonary toxicity of MCTP was examined in fawn-hooded (FH) rats, a strain with a platelet function defect. Both Sprague-Dawley (SD) and FH rats developed right ventricular hypertrophy and increased lung weights and exhibited decreased biogenic amine removal by isolated, perfused lung preparations after MCTP treatment. The responses of the FH rats were not significantly different from those of the SD rats, suggesting that platelet uptake and release of 5-hydroxytryptamine (5HT) are not the platelet functions involved in MCTP-induced pulmonary hypertension. The FH rats had an interesting strain-related difference from SD rats; isolated lungs from FH rats removed and metabolized a greater proportion of perfused 5HT than the SD rats.

Keywords

Pulmonary hypertension - Monocrotaline pyrrole - Dehydro-monocrotaline - Fawn-hooded rats - 5-hydroxytryptamine - Isolated lungs - Monocrotaline

• References

• 1 McLean EK. The toxic actions of pyrrolizidine (Senecio) alkaloids. Pharmacol Rev 1970; 22: 429-483
• 2 Meyrick B, Gamble W, Reid L. Development of Crotalaria pulmo-nary hypertension: hemodynamic and structural study. Am J Physiol 1980; 239: H692-H702
• 3 Chesney CF, Allen JR, Hsu IC. Right ventricular hypertrophy in monocrotaline pyrrole treated rats. Exp Mol Pathol 1974; 20: 257-268
• 4 Bruner LH, Hilliker KS, Roth RA. Pulmonary hypertension and EKG changes from monocrotaline pyrrole in the rat. Am J Physiol 1983; 245: 300-306
• 5 Gillis CN, Huxtable RJ, Roth RA. Effects of monocrotaline pretreatment of rats on removal of 5-hydroxytryptamine and noradrenaline by perfused lung. Br J Pharmacol 1978; 63: 435-443
• 6 Hilliker KS, Bell TG, Roth RA. Pneumotoxicity and thrombocy-topenia after single injection of monocrotaline. Am J Physiol 1982; 242: H573-H579
• 7 Roth RA, Hilliker KS, Bell TG. Effects of thrombocytopenia on the cardiopulmonary responses to monocrotaline pyrrole in the rat. (abstract) Fed Proc 1983; 43: 489
• 8 Tschopp TB, Zucker MB. Hereditary defect in platelet function in rats. Blood 1972; 40: 217-226
• 9 Raymond SL, Dodds WJ. Characterization of the fawn-hooded rat as a model for hemostatic studies. Thrombos Diathes Haemorrh 1975; 33: 361-369
• 10 Wey H, Gallon L, Subbiah MT R. Prostaglandin synthesis in aorta and platelets of fawn-hooded rats with platelet storage pool disease and its response to cholesterol feeding. Thromb Haemostas 1982; 48: 94-97
• 11 Mattocks AR. Dihydropyrrolizidine derivatives from unsaturated pyrrolizidine alkaloids. J Chem Soc 1969; C 1155-1162
• 12 Fulton RM, Hutchinson E, Jones AM. Ventricular weight in cardiac hypertrophy. Br Heart J 1952; 14: 413-420
• 13 Steel RG D, Torrie JH. Principles and Procedures of Statistics. McGraw-Hill; New York: 1960. pp 82-83, 106-107 194-203
• 14 Hollander M, Wolfe DA. Nonparametric Statistical Methods. John Wiley and Sons; New York: 1973. pp 68-75
• 15 Schalm O. Veterinary Hematology. Lea and Febiger; Philadelphia: 1975. p 241
• 16 Kreisberg JI, Kamovsky MJ. Focal glomerular sclerosis in the fawn-hooded rats. Am J Pathol 1978; 92: 637-652
• 17 Moore S, Friedman RJ, Singal DP, Gauldie J, Blajchman MA, Roberts RS. Inhibition of injury induced thromboatherosclerotic lesions by anti-platelet serum in rabbits. Thromb Haemostas 1976; 35: 70-81
• 18 Harker LA, Ross R, Slichter SJ, Scott RC. Homocystine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976; 58: 731-741
• 19 Till ML, Sussman II, Moss R, Drouet LC, Spaet TH. Production of experimental arteriosclerosis in fawn-hooded rats with platelet storage pool deficiency. Artery 1982; 10: 329-340
• 20 Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A₂and prostacyclin. Pharmacol Rev 1979; 30: 293-331
• 21 Gillis CN, Pitt BR. The fate of circulating amines within the pulmonary circulation. Ann Rev Physiol 1982; 44: 269-281
• 22 Pletscher A. Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. Br J Pharmacol Chemotherap 1968; 32: 1-16
• 23 Steinberg H, Das DK. Competition between platelets and lung for 5-hydroxytryptamine uptake. Exp Lung Res 1980; 1: 121-130